NFKB1 and breast cancer: Previous docking studies have reported NF-κB interactions with other molecules, including the study of Mukherjee et al., where it was shown that p65 interacts with protein lysine acetyltransferase CBP/p300, an important regulator of gene transcription [57] and genistein, a chemopreventive isoflavonoid known to inhibit the translocation and expression of NF-κB in the nucleus of various breast cancer cell lines [49].